BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28535156)

  • 21. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors.
    Seshadri RA; Rajendranath R
    J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal stromal tumours (GISTs): A descriptive study on 29 cases.
    Hamzaoui L; Medhioub M; Bouassida M; Mahmoudi M; El Bouchtili S; Ezzine H; Chelbi E; Touinsi H; Azouz MM
    Arab J Gastroenterol; 2016 Dec; 17(4):185-187. PubMed ID: 27964865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
    Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
    World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Resected Giant Gastrointestinal Stromal Tumor Associated with Intraperitoneal Bleeding Following Imatinib Administration].
    Ide R; Suzuki T; Takakura Y; Oshita A; Ikeda S; Matsugu Y; Nakahara H; Urushihara T; Itamoto T; Shinozaki K
    Gan To Kagaku Ryoho; 2016 Sep; 43(9):1121-4. PubMed ID: 27628557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
    Cavnar MJ; Seier K; Gönen M; Curtin C; Balachandran VP; Tap WD; Antonescu CR; Singer S; DeMatteo RP
    J Gastrointest Surg; 2021 Jul; 25(7):1828-1836. PubMed ID: 33169327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological complete response in a large gastric GIST that became resectable after neoadjuvant chemotherapy with imatinib mesylate].
    Otsubo D; Sawa H; Fukuoka E; Murata K; Mii Y; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2402-4. PubMed ID: 25731537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
    Namikawa T; Munekage E; Munekage M; Maeda M; Yatabe T; Kitagawa H; Sakamoto K; Obatake M; Kobayashi M; Hanazaki K
    Anticancer Res; 2016 Apr; 36(4):1855-9. PubMed ID: 27069170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months.
    Lei C; Zhao B; Wang Q; Ge L; Wang H
    J BUON; 2018; 23(2):460-467. PubMed ID: 29745093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
    Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
    Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
    Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
    Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S
    Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.
    Kyo K; Azuma M; Okamoto K; Nishiyama M; Shimamura T; Maema A; Kanamaru H; Shirakawa M; Nakamura T; Shinmura K; Koda K; Yokoyama H
    World J Surg Oncol; 2016 Mar; 14():68. PubMed ID: 26957123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal Stromal Tumors of the Stomach and Esophagus.
    Theiss L; Contreras CM
    Surg Clin North Am; 2019 Jun; 99(3):543-553. PubMed ID: 31047041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Giant Gastric Gastrointestinal Stromal Tumor Successfully Resected Following Neoadjuvant Treatment With Imatinib Mesylate.
    Takahashi R; Toyokawa T; Yoshii M; Tamura T; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
    Anticancer Res; 2020 Feb; 40(2):1147-1152. PubMed ID: 32014967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States.
    Bilimoria KY; Wayne JD; Merkow RP; Abbott DE; Cormier JN; Feig BW; Hunt KK; Pisters PW; Pollock R; Bentrem DJ
    Ann Surg Oncol; 2012 Jan; 19(1):184-91. PubMed ID: 21725688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Case of Gastric GIST with Pathological Complete Response Achieved by Long-Term Chemotherapy with Imatinib Mesylate].
    Kondo J; Chijimatsu H; Kijima T; Nagashima Y; Hayashi H; Morita K; Sakata K; Setoguchi M
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):515-517. PubMed ID: 29650923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ; Fitzgerald JE; Strauss DC; Hayes AJ; Thomas JM; Messiou C; Fisher C; Benson C; Tekkis PP; Judson I
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-year review of gastrointestinal stromal tumours at a tertiary referral hospital in New Zealand.
    Siu J; Lim M; Fischer J; Dobbs B; Wakeman C; Ing A; Frizelle F
    ANZ J Surg; 2016 Mar; 86(3):162-6. PubMed ID: 24325620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months.
    Jiang WZ; Guan GX; Lu HS; Yang YH; Kang DY; Huang HG
    J Surg Oncol; 2011 Dec; 104(7):760-4. PubMed ID: 21713778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.